Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP836046.RANhew3naE6c-GAQ2O6I3F0xh3F7zOK4AFfA2_ASn3nVo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP836046.RANhew3naE6c-GAQ2O6I3F0xh3F7zOK4AFfA2_ASn3nVo130_assertion type Assertion NP836046.RANhew3naE6c-GAQ2O6I3F0xh3F7zOK4AFfA2_ASn3nVo130_head.
- NP836046.RANhew3naE6c-GAQ2O6I3F0xh3F7zOK4AFfA2_ASn3nVo130_assertion description "[The aim of this prospective randomized study was to compare the safety and efficacy of enalapril (E) and losartan (L) in the treatment of posttransplantation erythrocytosis and the effect of the ACE genotype on response to therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836046.RANhew3naE6c-GAQ2O6I3F0xh3F7zOK4AFfA2_ASn3nVo130_provenance.
- NP836046.RANhew3naE6c-GAQ2O6I3F0xh3F7zOK4AFfA2_ASn3nVo130_assertion evidence source_evidence_literature NP836046.RANhew3naE6c-GAQ2O6I3F0xh3F7zOK4AFfA2_ASn3nVo130_provenance.
- NP836046.RANhew3naE6c-GAQ2O6I3F0xh3F7zOK4AFfA2_ASn3nVo130_assertion SIO_000772 11502994 NP836046.RANhew3naE6c-GAQ2O6I3F0xh3F7zOK4AFfA2_ASn3nVo130_provenance.
- NP836046.RANhew3naE6c-GAQ2O6I3F0xh3F7zOK4AFfA2_ASn3nVo130_assertion wasDerivedFrom befree-20140225 NP836046.RANhew3naE6c-GAQ2O6I3F0xh3F7zOK4AFfA2_ASn3nVo130_provenance.
- NP836046.RANhew3naE6c-GAQ2O6I3F0xh3F7zOK4AFfA2_ASn3nVo130_assertion wasGeneratedBy ECO_0000203 NP836046.RANhew3naE6c-GAQ2O6I3F0xh3F7zOK4AFfA2_ASn3nVo130_provenance.